Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...

Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks, Health Canada warns in public advisory.

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Thousands of patients desperate to access the “King Kong” of weight loss jabs are facing a postcode lottery, research reveals ...

The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...

Claire Reed, from Aberdeen in Scotland, was prescribed Mounjaro in March after she was left 'fed up' of not fitting into her ...

People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...

Noom claims its microdose approach allows users to lose up to 11 pounds (around 5kg) in one month and up to 17 pounds in two ...